Velano Vascular Revenue and Competitors

Claim your profile

Location

$71.2M

Total Funding

Estimated Revenue & Valuation

  • Velano Vascular's estimated annual revenue is currently $2.6M per year.(i)
  • Velano Vascular received $17.0M in venture funding in March 2017.
  • Velano Vascular's estimated revenue per employee is $125,500
  • Velano Vascular's total funding is $71.2M.

Employee Data

  • Velano Vascular has 21 Employees.(i)
  • Velano Vascular grew their employee count by -28% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M78-4%N/AN/A
#2
$3.5M34-8%N/AN/A
#3
$5.5M2283%N/AN/A
#4
$3.3M320%N/AN/A
#5
$5.8M23-28%N/AN/A
#6
$49.7M198-13%N/AN/A
#7
$9.8M39N/AN/AN/A
#8
$27.4M10911%N/AN/A
#9
$49.3M15728%$199.1MN/A
#10
$4.5M4416%N/AN/A

Velano Vascular is transforming the inpatient experience with the PIVO, a breakthrough needle-free blood collection device. PIVO aims to reduce painful needle sticks for inpatients, to improve practitioner safety, and to provide hospitals with a smarter financial solution for vascular access. Velano is backed by leading U.S. health systems including Sutter Health, Griffin Hospital and The Children's Hospital of Philadelphia, as well as First Round Capital, Kapor Capital, White Owl Capital, Safeguard Scientifics and dozens of heath industry veterans. Velano collaborates with innovators in patient-centered care, including Planetree, Intermountain Healthcare, Brigham & Women's Hospital and more. Our mission is to establish a new, more humane standard of care. We're looking for bright, tenacious candidates to join our incredible team of business and healthcare professionals. Check out our careers page here: http://velanovascular.com/careers/

keywords:Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$71.2M

Total Funding

21

Number of Employees

$2.6M

Revenue (est)

-28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Velano Vascular News

2022-04-17 - Needle Free Blood Drawing Devices Market Share, Growth ...

The major players covered in the needle free blood drawing devices market report are Velano Vascular, Inc., Siemens, Romsons, Tasso, Inc.,...

2019-12-17 - Velano taps $25M in new funding for its needle-free, bedside blood draw system

Velano Vascular, maker of a needle-free blood draw system, has closed a second tranche of new financing with $25 million to put toward its commercialization and launch of additional access products and medical devices for the inpatient setting. Sponsored by Agilent Technologies How would you l ...

2019-12-17 - Velano Vascular reels in $25M to keep building blood-draw business

“We refer to it as the one-stick hospitalization,” Eric Stone, Velano Vascular’s CEO, said in a phone interview. “Our aim, and I’ve been very open about this, is to make PIVO the standard of care around the world,” he said. More than a billion blood draws take place in inpatient settings per ye ...

2019-12-17 - Velano Vascular Closes Second Tranche of $25M Growth Financing

Velano Vascular, a San Francisco, Calif. – based vascular access technology company, closed the second tranche of a $25m growth financing. This new investment builds on an initial tranche closed in the first half of 2019 and brings total funding to more than $50 million from a mix of company in ...

2019-08-05 - Velano Primes for Growth with Funding from Intermountain ...

SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M210%$52M
#2
$1.4M21-52%$4.7M
#3
$1.5M21N/AN/A
#4
$2.1M21N/AN/A
#5
$2.1M21N/AN/A

Velano Vascular Funding

DateAmountRoundLead InvestorsReference
2014-11-14$0.4MUndisclosedArticle
2016-02-09$5.0MAMultipleArticle
2017-03-08$17.0MUndisclosedMultipleArticle